Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VKTX stock hub

Viking Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VKTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.6B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VKTX

In the news

Latest news · VKTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-70

P25 -105.6P50 -46.5P75 -3.1

ROIC-46.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VKTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001607678
Company name	Viking Therapeutics, Inc.
Country	United States
Country code	US
Cusip	92686J106
Employees	59
Employees Change	13%
Employees Change Percent	28.26
Enterprise value	$3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-04-29
Isin	US92686J1060
Last refreshed	2026-05-10
Market cap	$3.6B
Market cap category	Mid-Cap
Price	$31.33
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	VKTX
Website	https://www.vikingtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.98%
P/B ratio	7.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-472.3M
Net Income Growth Years	0%
Profit Per Employee	$-8M
ROA	-42.54
Roa5y	-21.32
ROCE	-100
ROE	-70.04
Roe5y	-32.87
ROIC	-46.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	38.13%
Cagr1y	13.69%
Cagr3y	11.08%
Cagr5y	39.65%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$608.2M
Cash	$603M
Current Assets	$608.2M
Current Liabilities	$106.3M
Equity	$501.9M
Interest Coverage	-15,687.4
Liabilities	$106.3M
Long Term Assets	$33,000
Long Term Liabilities	$0
Net Cash	$603M
Net Cash By Market Cap	$16.58
Net Cash Growth	-29.13%
Net Debt Equity	$-1.2
Tangible Book Value	$501.9M
Tangible Book Value Per Share	$4.33
WACC	8.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.72
Net Working Capital	$-101.1M
Quick ratio	5.67
Working Capital	$501.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	2,426.61%
1Y total return	13.68%
200-day SMA	32.75
3Y total return	37.05%
50-day SMA	33.39
50-day SMA vs 200-day SMA	50over200
5Y total return	431.02%
All Time High	99.41
All Time High Change	-68.48%
All Time High Date	2024-02-28
All Time Low	0.88
All Time Low Change	3,460.23%
All Time Low Date	2017-08-02
ATR	1.68
Beta	0.71
Beta1y	1.05
Beta2y	1.16
Ch YTD	-10.94
High	31.9
High52	43.15
High52 Date	2025-11-12
High52ch	-27.39%
Low	31.14
Low52	22.96
Low52 Date	2025-09-17
Low52ch	36.46%
Ma50ch	-6.18%
Premarket Change Percent	0.38
Premarket Price	$31.7
Premarket Volume	34,137
Price vs 200-day SMA	-4.32%
RSI	43.12
RSI Monthly	48.08
RSI Weekly	47.16
Sharpe ratio	0.54x
Sortino ratio	0.77
Total Return	-2.12%
Tr YTD	-10.94
Tr1m	-7.03%
Tr1w	4.43%
Tr3m	10.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	4
Analyst Price Target Top	$90.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.92
Operating Income	$-502M
Price target	$99.56
Price Target Change	$218
Price Target Change Top	$189

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,281,384%
Float Percent	97.57%
Shares Insiders	2.39%
Shares Institutions	62.55%
Shares Out	116,105,643
Shares Qo Q	1.37%
Shares Yo Y	2.12%
Short Float	20.4%
Short Ratio	10.03
Short Shares	19.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,370,431.1x
Bv Per Share	4.33
Ch10y	2,426.6
Ch1m	-7.03
Ch1w	4.43
Ch1y	13.68
Ch3m	10.16
Ch3y	37.05
Ch5y	431
Ch6m	-14.79
Change	-0.79%
Change From Open	-0.95
Close	31.58
Days Gap	0.16
Depreciation Amortization	405,000
Dollar Volume	45,382,382.2
Earnings Date	2026-04-29
Earnings Time	amc
EBIT	$-502M
EPS	$-4.16
F Score	1
Financing CF	88,167,000
Fiscal Year End	December
Founded	2,012
Investing CF	332,332,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-11
Ma150	33.82
Ma150ch	-7.37%
Ma20	33.1
Ma20ch	-5.34%
Net CF	80,176,000
Next Earnings Date	2026-07-22
Open	31.63
Optionable	Yes
Position In Range	25
Post Close	31.33
Postmarket Change Percent	0.19
Postmarket Price	$31.39
Pre Close	31.58
Price Date	2026-05-08
Ptbv Ratio	7.25
Relative Volume	0.62x
Share Based Comp	39,807,000
Tr6m	-14.79%
Us State	California
Volume	1,448,528

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VKTX pay a dividend?

Capital-return profile for this ticker.

Performance

VKTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VKTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+62.6%

Float: +97.6% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VKTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

-4.3%

50/200-day relationship not available

Beta (5Y)

0.71

Less volatile than the market

Sharpe ratio

0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VKTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VKTX stock rating?

Viking Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VKTX analysis?

The full report lives at /stocks/VKTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VKTX?

The latest report frames VKTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VKTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.